| Gene: | MUC5AC |
| GeneID: | ENSG00000215182 |
| Chrom: | 11 |
| Start position: | 1157953 |
| End position: | 1201138 |
| Pathway: | IL-17 signaling pathway |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.0726281 |
| Number of nsSNPs: | 16 |
| nsSNPs in gene: | rs36189285 rs878913005 rs878989392 rs74196458 rs1379396838 rs1469470921 rs1464458886 rs1554928355 rs1481236137 rs1487348067 rs1 |
| Gene Structure: | ![]() |
|
Overall distribution |
Tissue specific distribution |
|||
|
|
|
|||
|
Overall distribution |
Tissue specific distribution |
||||||
|
|
||||||
|
Overall distribution |
Tissue specific distribution |
||||
|
|
||||
| Functional class: | Not specified |
| JensenLab PubMed score: | 1630.64 (Percentile rank: 97.35%) |
| PubTator score: | 119.82 (Percentile rank: 80.10%) |
| Target development/druggability level: | TbioThese targets do not have known drug or small molecule activities that satisfy the activity thresholds detailed below AND satisfy one or more of the following criteria: 1) target is above the cutoff criteria for Tdark; 2) target is annotated with a Gene Ontology Molecular Function or Biological Process leaf term(s) with an Experimental Evidence code. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |